<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Guillon, C.</title>
    <link>http://repub.eur.nl/res/aut/2659/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Construction and characterisation of infectious recombinant HIV-1 clones containing CTL epitopes from structural proteins in Nef. (Article)</title>
      <link>http://repub.eur.nl/res/pub/3831/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>In this study the construction is described of HIV-1 molecular clones in which CTL epitopes from RT or Env late proteins were inserted into the Nef early protein. The ectopic epitopes were efficiently processed from the recombinant Nef proteins, were recognized by their cognate CTL in cytolytic assays, and did not perturb virus replication or viral protein expression in vitro. These recombinant viruses will therefore be an important tool in studying the effect of distinct epitope expression kinetics on the efficiency of CTL-mediated suppression of HIV-1 replication.</description>
    </item> <item>
      <title>Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction (Article)</title>
      <link>http://repub.eur.nl/res/pub/9859/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>In this study, we characterized the viral determinants of coreceptor usage in relation to susceptibility to antibody-mediated neutralization or enhancement of infectivity by using chimeras of three highly related human immunodeficiency virus type 1 (HIV-1) isolates of different phenotypes. We found that the V3 region was the main determinant of antibody-mediated enhancement and coreceptor specificity but that the overall structure of gp120 was also important for these properties. Constructs susceptible to antibody-mediated enhancement preferentially use CCR5 as a coreceptor, in contrast to constructs that were neutralized or not affected. Using monoclonal antibodies directed against CD4 or CCR5, we were able to show that antibody-mediated enhancement was CD4 dependent. Altogether, our results suggest that the modulation of the interaction of gp120 with CCR5 is the mechanism underlying antibody-mediated enhancement of HIV-1 infectivity.</description>
    </item> <item>
      <title>Macrophage tropism of human immunodeficiency virus type 1 facilitates in vivo escape from cytotoxic T-lymphocyte pressure. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12918/</link>
      <pubDate>2001-03-13T00:00:00Z</pubDate>
      <description>Early after seroconversion, macrophage-tropic human immunodeficiency virus type 1 (HIV-1) variants are predominantly found, even when a mixture of macrophage-tropic and non-macrophage-tropic variants was transmitted. For virus contracted by sexual transmission, this is presently explained by selection at the port of entry, where macrophages are infected and T cells are relatively rare. Here we explore an additional mechanism to explain the selection of macrophage-tropic variants in cases where the mucosa is bypassed during transmission, such as blood transfusion, needle-stick accidents, or intravenous drug abuse. With molecularly cloned primary isolates of HIV-1 in irradiated mice that had been reconstituted with a high dose of human peripheral blood mononuclear cells, we found that a macrophage-tropic HIV-1 clone escaped more efficiently from specific cytotoxic T-lymphocyte (CTL) pressure than its non-macrophage-tropic counterpart. We propose that CTLs favor the selective outgrowth of macrophage-tropic HIV-1 variants because infected macrophages are less susceptible to CTL activity than infected T cells.</description>
    </item> <item>
      <title>Broadening of coreceptor usage by human immunodeficiency virus type 2 does not correlate with increased pathogenicity in an in vivo model. (Article)</title>
      <link>http://repub.eur.nl/res/pub/3710/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>The pathogenic properties of four primary human immunodeficiency virus type 2 (HIV-2) isolates and two primary HIV-2 biological clones were studied in an in vivo human-to-mouse chimeric model. The cell-associated viral load and the ability to reduce the severity of the induced graft-versus-host disease symptoms, the CD4/CD8 ratio and the level of repopulation of the mouse tissues by the graft, were determined. All HIV-2 strains, irrespective of their in vitro biological phenotype, replicated to high titres and significantly reduced graft-versus-host disease symptoms as well as the CD4/CD8 ratios. Reduction of graft repopulation caused by infection with the respective HIV-2 strains showed that the in vitro replication rate, syncytium-inducing capacity and ability to infect human macrophages did influence the in vivo pathogenic potential whereas broadening of coreceptor usage did not.</description>
    </item> <item>
      <title>Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities (Article)</title>
      <link>http://repub.eur.nl/res/pub/8838/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>Entry of human immunodeficiency virus type 1 (HIV-1) into target cells is
      mediated by binding of the surface envelope glycoprotein to the CD4
      molecule. Interaction of the resulting CD4-glycoprotein complex with
      alpha- or beta-chemokine receptors, depending on the biological phenotype
      of the virus, then initiates the fusion process. Here, we show that
      primary HIV-2 isolates and biological clones, in contrast to those of
      HIV-1, may use a broad range of coreceptors, including CCR-1, CCR-3,
      CCR-5, and CXCR-4. The syncytium-inducing capacity of these viruses did
      not correlate with the ability to infect via CXCR-4 or any other
      coreceptor. One cell-free passage of the intermediate isolates in
      mitogen-stimulated, CD8+ cell-depleted peripheral blood mononuclear cells
      resulted in the outgrowth of variants with CCR-5 only, whereas the
      coreceptor usage of late and early isolates did not change. Since HIV-2 is
      less pathogenic in vivo than HIV-1, these data suggest that HIV
      pathogenicity in vivo is not directly related to the spectrum of
      coreceptors used in in vitro systems.</description>
    </item> <item>
      <title>Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities. (Article)</title>
      <link>http://repub.eur.nl/res/pub/3651/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>Entry of human immunodeficiency virus type 1 (HIV-1) into target cells is mediated by binding of the surface envelope glycoprotein to the CD4 molecule. Interaction of the resulting CD4-glycoprotein complex with alpha- or beta-chemokine receptors, depending on the biological phenotype of the virus, then initiates the fusion process. Here, we show that primary HIV-2 isolates and biological clones, in contrast to those of HIV-1, may use a broad range of coreceptors, including CCR-1, CCR-3, CCR-5, and CXCR-4. The syncytium-inducing capacity of these viruses did not correlate with the ability to infect via CXCR-4 or any other coreceptor. One cell-free passage of the intermediate isolates in mitogen-stimulated, CD8+ cell-depleted peripheral blood mononuclear cells resulted in the outgrowth of variants with CCR-5 only, whereas the coreceptor usage of late and early isolates did not change. Since HIV-2 is less pathogenic in vivo than HIV-1, these data suggest that HIV pathogenicity in vivo is not directly related to the spectrum of coreceptors used in in vitro systems.</description>
    </item>
  </channel>
</rss>